Skip to content
10-Q

Quarterly Report

ACRO BIOMEDICAL CO., LTD. ACBM

0001640334-23-001422

← back to feed
Filed
Aug 2, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Jul 31, 2023 60.04M sh
Current Liabilities Q1 2023 · Mar 31, 2023 $246.03K
Current Liabilities Q1 2023 · Dec 31, 2022 $201.12K
Current Assets Q1 2023 · Mar 31, 2023 $637.55K
Current Assets Q1 2023 · Dec 31, 2022 $657.54K
Total Assets Q1 2023 · Mar 31, 2023 $656.94K
Total Assets Q1 2023 · Dec 31, 2022 $687.49K
Gross Profit Q1 2023 · Mar 31, 2023 $0
Gross Profit Q1 2023 · Mar 31, 2022 $76.5K
Cost Of Revenue Q1 2023 · Mar 31, 2023 $0
Cost Of Revenue Q1 2023 · Mar 31, 2022 $222K
Operating Cash Flow Q1 2023 · Mar 31, 2022 $262.13K
Stockholders Equity Q1 2023 · Mar 31, 2022 $643.22K
Stockholders Equity Q1 2023 · Dec 31, 2021 $643.71K
Sga Expense Q1 2023 · Mar 31, 2022 $1.49M
Rd Expense Q1 2023 · Mar 31, 2022 $2.52M
Net Income Q1 2023 · Mar 31, 2022 −$3.93M
Operating Income Q1 2023 · Mar 31, 2022 −$3.93M
Revenue Q1 2023 · Mar 31, 2022 $298.5K